K

KUMMEL S.

Last name: KUMMEL S.

2021 (v1)

Publication

Metadata-only

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

Piccart M. van 't Veer L. J. Poncet C.

Background: The MINDACT trial showed excellent 5-year distant metastasis-free survival of 94·7% (95% CI 92·5–96·2) in patients with breast cancer of high clinical and low genomic risk who did not receive chemotherapy. We present long-term follow-up results together with an exploratory analysis by age. Methods: MINDACT was a multicentre,...

Uploaded on: April 14, 2023